-
Product Insights
NewSystemic Candidiasis – Drugs In Development, 2024
Empower your strategies with our Systemic Candidiasis – Drugs In Development, 2024 report and make more profitable business decisions. Systemic candidiasis encompasses a range of yeast infections resulting from various species of Candida, presenting a severe threat that can impact diverse areas of the body such as the blood, heart, brain, eyes, bones, and other organs. While there are over 200 Candida species, five specific types contribute to 90% of systemic candidiasis cases. The primary manifestation of this invasive yeast infection...
-
Product Insights
NewCandidiasis – Drugs In Development, 2024
Empower your strategies with our Candidiasis – Drugs In Development, 2024 report and make more profitable business decisions. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin; the folds of the buttocks; between...
-
Product Insights
NewAspergillosis – Drugs In Development, 2024
Empower your strategies with our Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Aspergillosis is an infection or allergic response due to the Aspergillus fungus. Symptoms include cough, fever, headaches, general ill feeling (malaise), weight loss, and chest pain. The predisposing factors include weakened immune system, low white blood cell level, asthma, and long-term corticosteroid therapy. Treatment includes oral corticosteroids, antifungals, and surgery. The Aspergillosis drugs in development market research report provide comprehensive information on the...
-
Product Insights
NewMycoses – Drugs In Development, 2024
Empower your strategies with our Mycoses – Drugs In Development, 2024 report and make more profitable business decisions. Mycoses, also known as fungal infections, encompass a diverse group of diseases caused by fungi. These infections can affect various tissues in the body, including the skin, nails, and internal organs. Superficial mycoses, like athlete's foot and ringworm, involve the outer layers, while systemic mycoses can affect deeper tissues and may be more severe, particularly in individuals with weakened immune systems. Candidiasis is...
-
Product Insights
NewCutaneous Mycosis – Drugs In Development, 2024
Empower your strategies with our Cutaneous Mycosis – Drugs In Development, 2024 report and make more profitable business decisions. Cutaneous mycoses are a group of superficial fungal infections that affect the skin, hair, and nails. They are also known as superficial mycoses. They are confined to the outer layers of the skin, hair, or nails. They rarely invade deeper tissues or viscera, and do not induce a cellular response from the host. Most cutaneous mycoses are caused by dermatophytes, a group...
-
Product Insights
NewOnychomycosis (Tinea Unguium) – Drugs In Development, 2024
Empower your strategies with our Onychomycosis (Tinea Unguium) – Drugs In Development, 2024 report and make more profitable business decisions. Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail, and pain of the finger or toe with ordinary activities. Treatment includes antifungal medications and surgery. The Onychomycosis (Tinea Unguium) drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
NewVulvovaginal Candidiasis – Drugs In Development, 2024
Empower your strategies with our Vulvovaginal Candidiasis – Drugs In Development, 2024 report and make more profitable business decisions. An excessive growth of yeast in the vagina that results in irritation, a local fungal infection caused by the Candida genus. It is most commonly seen in females in high estrogen states, pregnancy, oral contraceptive use, obesity, diabetes mellitus. It is not considered an STI although it can be transmitted by sexual intercourse. The Vulvovaginal Candidiasis drugs in development market research report...
-
Product Insights
NewDermatomycoses – Drugs In Development, 2024
Empower your strategies with our Dermatomycoses – Drugs In Development, 2024 report and make more profitable business decisions. Dermatomycosis is the most common form of fungal infection of the skin and skin appendages. Areas such as the warm, humid areas of feet and spaces between toes, and armpits are often colonized by fungi. Dermatomycoses are mainly caused by filamentous fungi, which feed on the keratin present in skin, hair and nails. The Dermatomycoses drugs in development market research report provide comprehensive...
-
Product Insights
NewAllergic Bronchopulmonary Aspergillosis – Drugs In Development, 2024
Empower your strategies with our Allergic Bronchopulmonary Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic bronchopulmonary aspergillosis (ABPA) is infection of the lung with Aspergillus fumigatus fungus in those with bronchial asthma, cystic fibrosis, or a compromised immune system. The disease effects are caused by a hypersensitivity reaction to antigens of the Aspergillus species. Clinical manifestations include bronchospasm, pulmonary infiltrates, eosinophilia, and immunologic evidence of allergy to the antigens of Aspergillus species. The Allergic Bronchopulmonary...
-
Product Insights
NewCryptococcosis – Drugs In Development, 2024
Empower your strategies with our Cryptococcosis – Drugs In Development, 2024 report and make more profitable business decisions. Cryptococcosis is infection caused by Cryptococcus neoformans fungus. Symptoms include cough, fatigue, fever, headache, nausea, and skin rashes. Predisposing factors include a weakened immune system, such as due to HIV infection; high-dose of corticosteroids; cancer chemotherapy; or Hodgkin's disease. Treatment includes antifungal drugs. The Cryptococcosis drugs in development market research report provide comprehensive information on the therapeutics under development for Cryptococcosis, complete with...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.